【结 构 式】 |
【分子编号】37816 【品名】1-(3-cyanophenyl)-3-methyl-1H-pyrazole-5-carboxylic acid 【CA登记号】 |
【 分 子 式 】C12H9N3O2 【 分 子 量 】227.22248 【元素组成】C 63.43% H 3.99% N 18.49% O 14.08% |
合成路线1
该中间体在本合成路线中的序号:(V)The cyclization of 3-bromophenylhydrazine (I) with 2-(trichloroacetyl)-3-methoxycrotonic acid (II) in refluxing ethanol gives, after chromatographic separation, 1-(3-bromophenyl)-3-methylpyrazole-5-carboxylic acid ethyl ester (III), which by reaction with CuCN in refluxing N-methylpyrrolidone is converted into the 3-cyanophenyl analogue (IV). The hydrolysis of (IV) with LiOH in THF/water affords the corresponding carboxylic acid (V), which by reaction with oxalyl chloride in dichloromethane gives the acyl chloride (VI). The condensation of (VI) with 4'-amino-N-tert-butylbiphenyl-2-sulfonamide (VII) by means of TEA in dichloromethane provides the corresponding amide (VIII), which is finally treated first with HCl in methanol, and then with ammonium carbonate in the same solvent.
【1】 Orwat, M.J.; Cacciola, J.; Han, Q.; Fevig, J.M.; Pinto, D.J.P.; Rossi, K.A.; Pruitt, J.R.; Quan, M.L. (DuPont Pharmaceuticals Co.); Nitrogen containing heteroaromatics as factor Xa inhibitors. EP 0946508; WO 9828269 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 37812 | 1-(3-bromophenyl)hydrazine | 27246-81-7 | C6H7BrN2 | 详情 | 详情 |
(II) | 37813 | (Z)-4-methoxy-2-(2,2,2-trichloroacetyl)-3-pentenoic acid | C8H9Cl3O4 | 详情 | 详情 | |
(III) | 37814 | ethyl 1-(3-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate | C13H13BrN2O2 | 详情 | 详情 | |
(IV) | 37815 | ethyl 1-(3-cyanophenyl)-3-methyl-1H-pyrazole-5-carboxylate | C14H13N3O2 | 详情 | 详情 | |
(V) | 37816 | 1-(3-cyanophenyl)-3-methyl-1H-pyrazole-5-carboxylic acid | C12H9N3O2 | 详情 | 详情 | |
(VI) | 37817 | 1-(3-cyanophenyl)-3-methyl-1H-pyrazole-5-carbonyl chloride | C12H8ClN3O | 详情 | 详情 | |
(VII) | 23363 | 4'-amino-N-(tert-butyl)[1,1'-biphenyl]-2-sulfonamide | C16H20N2O2S | 详情 | 详情 | |
(VIII) | 37818 | N-[2'-[(tert-butylamino)sulfonyl][1,1'-biphenyl]-4-yl]-1-(3-cyanophenyl)-3-methyl-1H-pyrazole-5-carboxamide | C28H27N5O3S | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(V)The cyclization of 3-bromophenylhydrazine (I) with 2-(trichloroacetyl)-3-methoxycrotonic acid (II) in refluxing ethanol gives, after chromatographic separation, 1-(3-bromophenyl)-3-methylpyrazole-5-carboxylic acid ethyl ester (III), which by reaction with CuCN in refluxing N-methylpyrrolidone is converted into the 3-cyanophenyl analogue (IV). The hydrolysis of (IV) with LiOH in THF/water affords the corresponding carboxylic acid (V), which by reaction with oxalyl chloride in dichloromethane gives the acyl chloride (VI). The condensation of (VI) with 2-(2-aminopyrimidin-4-yl)-N-tert-butylbenzenesulfonamide (VII) by means of TEA in dichloromethane provides the corresponding amide (VIII), which is finally treated first with HCl in methanol, and then with ammonium carbonate in the same solvent.
【1】 Orwat, M.J.; Cacciola, J.; Han, Q.; Fevig, J.M.; Pinto, D.J.P.; Rossi, K.A.; Pruitt, J.R.; Quan, M.L. (DuPont Pharmaceuticals Co.); Nitrogen containing heteroaromatics as factor Xa inhibitors. EP 0946508; WO 9828269 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 37812 | 1-(3-bromophenyl)hydrazine | 27246-81-7 | C6H7BrN2 | 详情 | 详情 |
(II) | 37813 | (Z)-4-methoxy-2-(2,2,2-trichloroacetyl)-3-pentenoic acid | C8H9Cl3O4 | 详情 | 详情 | |
(III) | 37814 | ethyl 1-(3-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate | C13H13BrN2O2 | 详情 | 详情 | |
(IV) | 37815 | ethyl 1-(3-cyanophenyl)-3-methyl-1H-pyrazole-5-carboxylate | C14H13N3O2 | 详情 | 详情 | |
(V) | 37816 | 1-(3-cyanophenyl)-3-methyl-1H-pyrazole-5-carboxylic acid | C12H9N3O2 | 详情 | 详情 | |
(VI) | 37817 | 1-(3-cyanophenyl)-3-methyl-1H-pyrazole-5-carbonyl chloride | C12H8ClN3O | 详情 | 详情 | |
(VII) | 34823 | 2-(2-amino-5-pyrimidinyl)-N-(tert-butyl)benzenesulfonamide | C14H18N4O2S | 详情 | 详情 | |
(VIII) | 37819 | N-(5-[2-[(tert-butylamino)sulfonyl]phenyl]-2-pyrimidinyl)-1-(3-cyanophenyl)-3-methyl-1H-pyrazole-5-carboxamide | C26H25N7O3S | 详情 | 详情 |